ORNL News

New Tech Mines Old Batteries to Find Critical Ingredients for Electric Vehicles

Recycling batteries is time-consuming and involves dangerous chemicals. This new process could make it easier—and reduce the amount of mining required to fuel the clean energy economy.
By |April 12th, 2021||0 Comments|

ORNL-Led Team Recognized for Impactful Sustainability Research

An analysis published in the Proceedings of the National Academy of Sciences and led by researchers from the U.S. Department of Energy’s Oak Ridge National Laboratory has received the 2021 Sustainability Science Award from the Ecological Society of America. The team used high-resolution geospatial modeling to quantify the effects of land, energy and water infrastructures on the nation’s rivers and streams.
By |April 7th, 2021||0 Comments|

EM Removes Tritium Facility at ORNL

EM crews have completed demolition on a contaminated 1960s-era building at the Oak Ridge National Laboratory (ORNL), opening land that DOE can reuse for future missions. With the Tritium Target Preparation Facility removed, crews can address the soils and substructures associated with the building. The cleanup effort eliminated several contaminated areas, allowing for a transformation in a location that can support the Department in the years ahead.
By |April 7th, 2021||0 Comments|

ORNL Joins ATOM Consortium to Accelerate Drug Discovery

The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
By |March 31st, 2021||0 Comments|

Neutrons Reveal Unpredicted Binding Between SARS-CoV-2, Hepatitis C Antiviral Drug

Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce. Published in the Journal of Medicinal Chemistry, the research provides key insights for advancing drug design and drug repurposing efforts to treat COVID-19.
By |March 24th, 2021||0 Comments|